PI
BSX icon

PEAK6 Investments’s Boston Scientific BSX Stock Holding History

PEAK6 Investments’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$7.26M Buy
86,600
+34,000
+65% +$2.68M 0.02% 735
2024
Q2 		$4.05M Sell
52,600
-82,100
-61% -$6.01M 0.01% 963
2024
Q1 		$9.23M Buy
134,700
+68,400
+103% +$4.4M 0.02% 557
2023
Q4 		$3.83M Sell
66,300
-16,500
-20% -$881K 0.01% 1026
2023
Q3 		$4.37M Buy
82,800
+63,000
+318% +$3.3M 0.02% 794
2023
Q2 		$1.07M Sell
19,800
-66,600
-77% -$3.48M ﹤0.01% 1671
2023
Q1 		$4.32M Sell
86,400
-93,600
-52% -$4.41M 0.02% 789
2022
Q4 		$8.33M Buy
180,000
+30,300
+20% +$1.31M 0.05% 450
2022
Q3 		$5.8M Buy
149,700
+61,500
+70% +$2.47M 0.02% 743
2022
Q2 		$3.62M Sell
88,200
-53,300
-38% -$2.17M 0.01% 1692
2022
Q1 		$6.27M Sell
141,500
-150,900
-52% -$6.54M 0.01% 946
2021
Q4 		$12.4M Buy
292,400
+197,100
+207% +$8.28M 0.03% 616
2021
Q3 		$4.13M Sell
95,300
-41,600
-30% -$1.84M 0.01% 1303
2021
Q2 		$5.85M Buy
136,900
+81,500
+147% +$3.43M 0.01% 1002
2021
Q1 		$2.14M Sell
55,400
-303,900
-85% -$11.5M 0.01% 1806
2020
Q4 		$12.9M Buy
359,300
+229,300
+176% +$8.26M 0.03% 556
2020
Q3 		$4.97M Buy
130,000
+83,400
+179% +$3.21M 0.01% 954
2020
Q2 		$1.64M Sell
46,600
-26,300
-36% -$947K 0.01% 1657
2020
Q1 		$2.38M Buy
72,900
+10,100
+16% +$395K 0.01% 918
2019
Q4 		$2.84M Buy
62,800
+12,300
+24% +$515K 0.01% 891
2019
Q3 		$2.06M Sell
50,500
-60,300
-54% -$2.55M 0.01% 1256
2019
Q2 		$4.76M Buy
110,800
+110,500
+36,833% +$4.25M 0.03% 731
2019
Q1 		$12K Sell
300
-1,029,900
-100% -$39.3M ﹤0.01% 3612
2018
Q4 		$36.4M Buy
1,030,200
+1,020,600
+10,631% +$37M 0.23% 70
2018
Q3 		$370K Buy
+9,600
New +$335K ﹤0.01% 2803

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

PEAK6 Investments's BSX Position: Q3 2024 in Review

PEAK6 Investments reduced its Boston Scientific (BSX) stake by 58% in Q3 2024, selling an estimated $1.3M and leaving 11,772 shares worth $986K. The position accounts for ﹤0.01% of the portfolio, ranked #1917.

PEAK6 Investments first reported a position in BSX in Q1 2019 and has held it in 17 quarters since. The position peaked at $5.03M in Q2 2022. 1,396 funds tracked by Wall St. Rank hold BSX as of Q3 2024.

  • PEAK6 Investments held 11,772 shares of Boston Scientific worth $986K as of Q3 2024.
  • PEAK6 Investments sold 16,513 Boston Scientific shares in Q3 2024, an estimated $1.3M.
  • Boston Scientific made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #1917 holding.
  • PEAK6 Investments first reported a position in Boston Scientific in Q1 2019 and has held it in 17 quarters since.
  • PEAK6 Investments's Boston Scientific position peaked at $5.03M in Q2 2022.
  • 1,396 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.